PL3319970T3 - Pochodne pirydo-oksazynonu jako inhibitory tnap - Google Patents
Pochodne pirydo-oksazynonu jako inhibitory tnapInfo
- Publication number
- PL3319970T3 PL3319970T3 PL16775006T PL16775006T PL3319970T3 PL 3319970 T3 PL3319970 T3 PL 3319970T3 PL 16775006 T PL16775006 T PL 16775006T PL 16775006 T PL16775006 T PL 16775006T PL 3319970 T3 PL3319970 T3 PL 3319970T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrido
- tnap inhibitors
- oxazinone derivatives
- oxazinone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562190145P | 2015-07-08 | 2015-07-08 | |
| EP16775006.6A EP3319970B1 (en) | 2015-07-08 | 2016-07-07 | Pyrido-oxazinone derivatives as tnap inhibitors |
| PCT/US2016/041345 WO2017007943A1 (en) | 2015-07-08 | 2016-07-07 | Pyrido-oxazinone derivatives as tnap inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3319970T3 true PL3319970T3 (pl) | 2020-03-31 |
Family
ID=57045381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16775006T PL3319970T3 (pl) | 2015-07-08 | 2016-07-07 | Pochodne pirydo-oksazynonu jako inhibitory tnap |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US9920068B2 (pl) |
| EP (1) | EP3319970B1 (pl) |
| JP (1) | JP6666928B2 (pl) |
| KR (1) | KR102590067B1 (pl) |
| CN (1) | CN107207527B (pl) |
| AU (1) | AU2016291163B2 (pl) |
| CA (1) | CA2962795C (pl) |
| CO (1) | CO2017003830A2 (pl) |
| CY (1) | CY1122477T1 (pl) |
| DK (1) | DK3319970T3 (pl) |
| ES (1) | ES2754480T3 (pl) |
| HK (1) | HK1253572A1 (pl) |
| HR (1) | HRP20192121T1 (pl) |
| HU (1) | HUE046994T2 (pl) |
| IL (1) | IL251005B (pl) |
| LT (1) | LT3319970T (pl) |
| MX (1) | MX2017003822A (pl) |
| MY (1) | MY185558A (pl) |
| PH (1) | PH12018500066A1 (pl) |
| PL (1) | PL3319970T3 (pl) |
| PT (1) | PT3319970T (pl) |
| RS (1) | RS59594B1 (pl) |
| RU (1) | RU2715704C2 (pl) |
| SG (1) | SG11201701378WA (pl) |
| SI (1) | SI3319970T1 (pl) |
| TW (1) | TWI702220B (pl) |
| WO (1) | WO2017007943A1 (pl) |
| ZA (1) | ZA201701783B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11046710B2 (en) | 2016-12-23 | 2021-06-29 | Daiichi Sankyo Company, Limited | Sulfonamide compounds |
| WO2018119449A1 (en) * | 2016-12-23 | 2018-06-28 | Daiichi Sankyo Company, Limited | Oxazepine derivatives having tnap inhibitory activity |
| US11932600B2 (en) | 2018-10-23 | 2024-03-19 | Daiichi Sankyo Company Limited | Biaryl derivative |
| CN114085911B (zh) * | 2022-01-19 | 2022-05-17 | 珠海圣美生物诊断技术有限公司 | 一种检测肿瘤细胞或肿瘤细胞碎片的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4810795A (en) | 1982-09-30 | 1989-03-07 | A. H. Robins Company, Incorporated | Certain 2,5 and 2,5,6-di- and tri-substituted nicotinic acid intermediates |
| CA2352612A1 (en) | 1998-11-27 | 2000-06-08 | Hideo Fukui | Pharmaceuticals |
| PE20011061A1 (es) * | 2000-02-01 | 2001-11-20 | Procter & Gamble | Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato |
| WO2007007040A1 (en) | 2005-07-09 | 2007-01-18 | Astrazeneca Ab | 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| EP2164329A4 (en) | 2007-05-08 | 2010-11-17 | Burnham Inst Medical Research | NON-TISSUE-SPECIFIC ALKALI PHOSPHATASE INHIBITORS AND THEIR USE FOR THE TREATMENT OF VASCULAR SCALES |
| EP2817292B1 (en) | 2012-02-22 | 2019-12-18 | Sanford-Burnham Medical Research Institute | Sulfonamide compounds and uses as tnap inhibitors |
-
2016
- 2016-07-07 RU RU2017117179A patent/RU2715704C2/ru active
- 2016-07-07 DK DK16775006T patent/DK3319970T3/da active
- 2016-07-07 MY MYPI2017700569A patent/MY185558A/en unknown
- 2016-07-07 SG SG11201701378WA patent/SG11201701378WA/en unknown
- 2016-07-07 RS RS20191522A patent/RS59594B1/sr unknown
- 2016-07-07 HU HUE16775006A patent/HUE046994T2/hu unknown
- 2016-07-07 PL PL16775006T patent/PL3319970T3/pl unknown
- 2016-07-07 TW TW105121542A patent/TWI702220B/zh active
- 2016-07-07 EP EP16775006.6A patent/EP3319970B1/en active Active
- 2016-07-07 PT PT167750066T patent/PT3319970T/pt unknown
- 2016-07-07 LT LT16775006T patent/LT3319970T/lt unknown
- 2016-07-07 WO PCT/US2016/041345 patent/WO2017007943A1/en active Application Filing
- 2016-07-07 MX MX2017003822A patent/MX2017003822A/es active IP Right Grant
- 2016-07-07 US US15/314,887 patent/US9920068B2/en active Active
- 2016-07-07 JP JP2017556523A patent/JP6666928B2/ja active Active
- 2016-07-07 CA CA2962795A patent/CA2962795C/en active Active
- 2016-07-07 SI SI201630466T patent/SI3319970T1/sl unknown
- 2016-07-07 CN CN201680006507.5A patent/CN107207527B/zh active Active
- 2016-07-07 AU AU2016291163A patent/AU2016291163B2/en active Active
- 2016-07-07 ES ES16775006T patent/ES2754480T3/es active Active
- 2016-07-07 KR KR1020177010518A patent/KR102590067B1/ko active IP Right Grant
-
2017
- 2017-03-07 IL IL251005A patent/IL251005B/en active IP Right Grant
- 2017-03-13 ZA ZA2017/01783A patent/ZA201701783B/en unknown
- 2017-04-06 US US15/481,151 patent/US9879032B2/en active Active
- 2017-04-20 CO CONC2017/0003830A patent/CO2017003830A2/es unknown
-
2018
- 2018-01-05 PH PH12018500066A patent/PH12018500066A1/en unknown
- 2018-01-18 US US15/874,768 patent/US10221195B2/en active Active
- 2018-10-08 HK HK18112777.4A patent/HK1253572A1/zh unknown
-
2019
- 2019-11-27 HR HRP20192121TT patent/HRP20192121T1/hr unknown
- 2019-11-27 CY CY20191101247T patent/CY1122477T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278916A (en) | Benzoimidazole derivatives as PAD4 inhibitors | |
| LT3371190T (lt) | Heterocikliniai junginiai, kaip pi3k-gama inhibitoriai | |
| IL246785A0 (en) | Benzimidazole-2-amines as midh1 inhibitors | |
| HK1226398A1 (zh) | 作為midh1抑制劑的苯並咪唑-2-胺 | |
| HK1251566A1 (zh) | 作為hdac1/2抑制劑的呱啶衍生物 | |
| HRP20190127T1 (hr) | Derivati pirolidinona kao inhibitori metap-2 | |
| IL246345A0 (en) | History of 5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid as neprilysin inhibitors | |
| HK1232227A1 (zh) | 作為 抑制劑的喹嗪酮衍生物 | |
| HK1253572A1 (zh) | 作為tnap抑制劑的吡啶並噁嗪酮化合物 | |
| HK1251572A1 (zh) | 作為ddr1抑制劑的三氮雜-螺癸酮類化合物 | |
| IL252866A0 (en) | History of imidazopyridazine as pi3kbeta inhibitors | |
| HK1252767A1 (zh) | 作為eaat3抑制劑的吡唑-吡啶衍生物 | |
| EP3526216C0 (en) | BENZOTHIAZOLE DERIVATIVES AS DYRK1 INHIBITORS |